Hangzhou Tigermed Consulting (03347): FRONTAGE temporarily suspended from October 22 pending publication of inside information
Hangzhou Tigermed Consulting (03347) announced that the Company noted that trading in the shares of FRONTAGE (01521.HK), a subsidiary of the Company, on The Stock Exchange of Hong Kong Limited has been temporarily suspended with effect from 9:00 a.m. on October 22, 2026, pending the release by FRONTAGE of an announcement containing inside information of FRONTAGE in accordance with the Hong Kong Code on Takeovers and Mergers.
Hangzhou Tigermed Consulting (03347) issued an announcement that the Company noted that trading in the shares of FRONTAGE (01521.HK), a subsidiary of the Company, has been temporarily suspended on The Stock Exchange of Hong Kong Limited with effect from 9:00 a.m. on October 22, 2026, pending the release by FRONTAGE of an announcement containing inside information of FRONTAGE in accordance with the Hong Kong Code on Takeovers and Mergers.
Related Articles
CITIC SEC: National Data Group Established; Attention to Opportunities in Scarcity Data Circulation and Infra Construction
Academicians Appraise Innovations, Nationwide First in the Energy Storage Industry | Excellence Ruixin (02687) Discipline Large Model Lands at Tianjin University
CICC: Cuts CHINA TOWER (00788) 2026/27 net profit forecasts; maintains "Outperform" rating and HK$11 target price.
CITIC SEC: National Data Group Established; Attention to Opportunities in Scarcity Data Circulation and Infra Construction
Academicians Appraise Innovations, Nationwide First in the Energy Storage Industry | Excellence Ruixin (02687) Discipline Large Model Lands at Tianjin University
CICC: Cuts CHINA TOWER (00788) 2026/27 net profit forecasts; maintains "Outperform" rating and HK$11 target price.
